
Results
21
Companies which are more than 50% undervalued based on analyst price target.
21 companies
ABL Bio
Market Cap: ₩5.0t
A biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases.
A298380
₩86,800.00
7D
8.2%
1Y
6.4%
LigaChem Biosciences
Market Cap: ₩4.3t
A clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs.
A141080
₩115,100.00
7D
5.1%
1Y
-26.1%
Voronoi
Market Cap: ₩3.2t
Researches, develops, and discovers small molecule kinase inhibitors in South Korea.
A310210
₩174,900.00
7D
18.6%
1Y
43.1%
Hanall Biopharma
Market Cap: ₩2.9t
A pharmaceutical company, manufactures and sells pharmaceutical products in South Korea and internationally.
A009420
₩55,800.00
7D
5.1%
1Y
91.1%
ST PharmLtd
Market Cap: ₩2.3t
Provides manufacturing services for active pharmaceutical ingredient and intermediate.
A237690
₩107,000.00
7D
6.2%
1Y
14.2%
L&C BIOLTD
Market Cap: ₩1.7t
Operates as a research and development company in tissue regeneration medicine.
A290650
₩56,800.00
7D
-1.7%
1Y
80.3%
Daewoong Pharmaceutical
Market Cap: ₩1.5t
Develops, manufactures and commercializes pharmaceutical products in South Korea and internationally.
A069620
₩124,800.00
7D
0.2%
1Y
-5.5%
Oscotec
Market Cap: ₩1.4t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩38,800.00
7D
15.5%
1Y
15.0%
HK inno.N
Market Cap: ₩1.2t
Engages in the pharmaceutical business in South Korea.
A195940
₩41,650.00
7D
2.8%
1Y
-5.8%
DongKook Pharmaceutical
Market Cap: ₩967.6b
Produces and sells pharmaceutical products in South Korea and internationally.
A086450
₩21,600.00
7D
17.9%
1Y
22.7%
Chong Kun Dang Pharmaceutical
Market Cap: ₩936.8b
Manufactures, markets, and sells medicines in South Korea and internationally.
A185750
₩69,300.00
7D
2.7%
1Y
-16.2%
Boryung
Market Cap: ₩779.8b
Engages in the manufacture and sale of pharmaceutical products in South Korea and internationally.
A003850
₩9,210.00
7D
6.0%
1Y
9.3%
AprilBioLtd
Market Cap: ₩700.1b
Develops long-acting type biobetter and antibody biologics.
A397030
₩28,500.00
7D
7.3%
1Y
30.4%
Pharmicell
Market Cap: ₩695.4b
A biopharmaceutical company, develops and sells autologous drugs in South Korea and internationally.
A005690
₩11,820.00
7D
3.5%
1Y
0%
Dong-A Socio Holdings
Market Cap: ₩643.0b
Engages in the pharmaceutical business in South Korea.
A000640
₩95,050.00
7D
8.6%
1Y
-13.1%
Dong-A ST
Market Cap: ₩382.7b
Develops, manufactures, and markets pharmaceutical products in South Korea and internationally.
A170900
₩38,850.00
7D
4.4%
1Y
-10.8%
Humedix
Market Cap: ₩290.0b
Engages in the manufacture and sale of various pharmaceutical products in South Korea.
A200670
₩27,900.00
7D
-1.6%
1Y
-54.3%
BINEX
Market Cap: ₩244.0b
Operates as a pharmaceutical company in South Korea.
A053030
₩7,500.00
7D
7.3%
1Y
-54.9%
Whan In PharmLtd
Market Cap: ₩192.4b
Manufactures and sells various pharmaceutical products in South Korea.
A016580
₩10,180.00
7D
1.1%
1Y
-11.8%
Daewon Pharmaceutical
Market Cap: ₩176.8b
A pharmaceutical company, manufactures and sells medicines and medical supplies in South Korea.
A003220
₩8,200.00
7D
5.7%
1Y
-38.2%
Macrogen
Market Cap: ₩137.9b
Provides precision medicine and bio-engineering healthcare services in Korea and internationally.
A038290
₩12,600.00
7D
5.4%
1Y
-20.9%